News overview Healthcare & Biotech

Scholar Rock says FDA review of its marketing application for apitegromab in spinal muscular atrophy is ongoing, with a decision date expect...

SRRK 2 days ago

52.05 0.89 %

Keros Therapeutics announced the triggering of a $20 million milestone payment from partner Takeda, following the first dosing of a patient ...

KROS 2 days ago

10.10 5.25 %

AbCellera Biologics is benefiting from a series of favorable announcements, notably encouraging Phase 2 results for ABCL635 in menopausal ho...

ABCL 2 days ago

11.20 1.58 %

BeOne Medicines reported a particularly strong second quarter of 2026, with revenue up 30% thanks to very robust sales growth for BRUKINSA. ...

ONC 2 days ago

362.51 4.33 %

MacroGenics said Gilead Sciences has exercised its option to obtain an exclusive license for a preclinical bispecific program arising from t...

MGNX 2 days ago

4.02 2.55 %

Heartflow hit an all-time high after posting second-quarter results that topped expectations, with revenue up 48% to $64.1 million. The comp...

HTFL 2 days ago

41.95 0.32 %